MK

Mark Jeroen Kwakkenbos

AB Aimm Therapeutics B.V.: 2 patents #2 of 12Top 20%
Genentech: 1 patents #172 of 467Top 40%
ML Medimmune Limited: 1 patents #31 of 168Top 20%
Overall (2018): #65,605 of 503,207Top 15%
3
Patents 2018

Issued Patents 2018

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
10059757 RSV-specific binding molecules and means for producing them Hergen Spits, Tim Beaumont, Etsuko Yasuda 2018-08-28
9969795 Means and methods for producing high affinity antibodies Tim Beaumont, Hergen Spits, Adrianus Q. Bakker, Koen Wagner 2018-05-15
9927428 Gram-positive bacteria specific binding compounds Tim Beaumont, Eric J. Brown, John Hiroshi Morisaki, Wouter Hazenbos, Sanjeev Mariathasan +2 more 2018-03-27